Intravenous inducing agent with maximum plasma protein binding
**Core Concept**
The question is testing knowledge of the pharmacokinetics of intravenous anesthetics, specifically their plasma protein binding. Plasma protein binding refers to the degree to which a drug binds to plasma proteins, such as albumin, which can affect its distribution, metabolism, and excretion.
**Why the Correct Answer is Right**
The correct answer is **Propofol**. Propofol has a high degree of plasma protein binding, approximately 98-99%. This means that a significant portion of propofol is bound to albumin and other plasma proteins, which can affect its free fractions and distribution to target tissues. The high protein binding of propofol also contributes to its rapid redistribution and clearance from the body.
**Why Each Wrong Option is Incorrect**
**Option A:** **Etomidate** has a lower degree of plasma protein binding compared to propofol, approximately 76-77%. This makes it a less likely candidate for the correct answer.
**Option B:** **Ketamine** has a relatively low degree of plasma protein binding, approximately 12%. This makes it an even less likely candidate.
**Option C:** **Midazolam** has a moderate degree of plasma protein binding, approximately 50-60%. While this is higher than ketamine, it is still lower than propofol.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that plasma protein binding can affect the pharmacokinetics of intravenous anesthetics, including their distribution, metabolism, and excretion. This knowledge is crucial for understanding the clinical effects and potential interactions of these agents.
**Correct Answer:** D. Propofol